Susan Owen

Berkshire Biomedical LLC is a medical device company that is pioneering the use of biometric technologies to provide precise and accurate personalized medication delivery to only the authenticated intended user. The private company is based in Dallas, TX. The company's lead product under development is the computerized oral prescription administration system (COPA), a hand-held, automated, personalized oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the authenticated intended user upon confirmation of dual biometric identification. The company was founded in 2016 by Thomas M. Rouse, Susan Owen. John E. Timberlake has been the CEO of the company since 2021.

Berkshire Biomedical LLC is a medical device company that is pioneering the use of biometric technologies to provide precise and accurate personalized medication delivery to only the authenticated intended user. The private company is based in Dallas, TX. The company's lead product under development is the computerized oral prescription administration system (COPA), a hand-held, automated, personalized oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the authenticated intended user upon confirmation of dual biometric identification. The company was founded in 2016 by Thomas M. Rouse, Susan Owen. John E. Timberlake has been the CEO of the company since 2021.

Berkshire Biomedical LLC is a medical device company that is pioneering the use of biometric technologies to provide precise and accurate personalized medication delivery to only the authenticated intended user. The private company is based in Dallas, TX. The company's lead product under development is the computerized oral prescription administration system (COPA), a hand-held, automated, personalized oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the authenticated intended user upon confirmation of dual biometric identification. The company was founded in 2016 by Thomas M. Rouse, Susan Owen. John E. Timberlake has been the CEO of the company since 2021.